A research reference and ASEAN distribution partner for Hydroxyapatite-LC — a Japanese-patented functional ingredient manufactured under Japanese Quasi-Drug Raw Material standards. Technicity Pte. Ltd. (Singapore) is the appointed ASEAN representative, connecting formulation teams and ingredient buyers with the manufacturer in Japan.
The primary mineral component of human teeth and bone — and one of the most biocompatible materials known to formulation science.
Hydroxyapatite (Ca₁₀(PO₄)₆(OH)₂) is a calcium phosphate mineral that forms the inorganic matrix of human bones and teeth. It accounts for approximately 97% of tooth enamel and 65–70% of bone by weight. It is not a synthetic foreign material — it is the mineral your body already produces and maintains throughout your lifetime.
Research into synthetic hydroxyapatite began in earnest in the 1970s, when NASA studied calcium mineral loss in astronauts during spaceflight. This work established the foundation for what is now a well-characterised, extensively peer-reviewed ingredient with approval status in Japan, the EU (SCCS), and Canada for oral care applications.
The key advancement of the past two decades has been the production of nano-hydroxyapatite (nHAP) — particles sized 20–80 nm that match the scale of the crystalline structures found in natural enamel. At this size, the material can access the micro-defects in enamel that are the entry point for caries, staining, and sensitivity.
EU Safety Classification: The Scientific Committee on Consumer Safety (SCCS) has confirmed nano-hydroxyapatite is safe for use in oral care formulations at concentrations up to 29.5%. The EU maintains among the world's most stringent cosmetic ingredient standards.
Fills micro-defects in enamel, adsorbs cariogenic bacteria (S. mutans), reduces dentine sensitivity, and supports whitening without abrasion.
Oral CarePhysically captures odour-causing bacteria and fungi via surface adsorption — a chemical-free deodorant mechanism. Relevant to aluminium-free personal care.
Body Care / DeodorantGHS-confirmed non-hazardous. Biocompatible mineral base suitable for baby care, maternity products, and sensitive skin formulations where safety claims are primary.
Sensitive / Baby CareSource material and manufacturing process determine functional performance. This comparison documents the critical technical differences between general mineral-derived HAP and purpose-engineered functional-grade material.
| Criterion | General mineral-derived HAP | Hydroxyapatite-LC |
|---|---|---|
| Raw material origin | Mineral-derived (limestone). Common mineral source. | Two grades: mineral-derived (limestone) and eggshell-derived (recycled eggshell waste). Both Japan, same patented process. |
| Manufacturing process | Standardised processes with potential for variability between producers. Less precise control. | Patented, highly controlled and stable manufacturing process, ensuring uniformity. |
| Particle consistency | Inconsistent particle size and shape, leading to higher lot-to-lot variation. Less predictable performance. | Precisely controlled particle size and morphology for minimal lot-to-lot variation. Consistent performance. |
| Quality standard | General industrial standards, may not be optimised for oral or cosmetic use. Focus on bulk application. | Quality design based on Japanese Quasi-Drug Raw Material standards. Optimised for cosmetic and oral care. |
| Purity and impurity control | Management of impurities like heavy metals can be inconsistent or unclear. Requires further testing. | Rigorous and clearly defined management of impurities, ensuring high purity. Strict criteria. |
| Safety profile (GHS) | Safety data may vary; not always classified with oral care use in mind. Potential for classification ambiguity. | Confirmed as non-hazardous under GHS, ensuring high safety for intended use. Safe and approved. |
| Designed application | Often a general-purpose mineral powder for broad industrial use. Not specialised. | Specifically designed and optimised for cosmetic and oral care applications. Tailored performance. |
| Quality assurance | Quality control standards vary by country and manufacturer. Less rigorous overall oversight. | 100% manufactured and quality controlled under strict standards in Japan. Complete oversight. |
Quality Beyond the Source: the critical difference lies not in the source rock, but in the precision of the manufacturing process and the purpose of the design. Functional-grade HAP for cosmetic and oral care applications requires particle consistency and quality oversight that general industrial-grade material does not provide.
Three independently documented mechanisms make hydroxyapatite a multi-functional oral care ingredient — addressing remineralisation, biofilm management, and sensitivity in a single material.
Nano-HAP particles integrate into demineralised enamel zones, restoring the mineral matrix that acid erosion and brushing remove over time. Unlike fluoride, which converts hydroxyapatite to fluorapatite, nano-HAP deposits the same mineral the tooth is already composed of. Multiple RCTs confirm remineralisation efficacy comparable to sodium fluoride at equivalent concentrations.
Hydroxyapatite adsorbs Streptococcus mutans (primary cariogenic pathogen) and Porphyromonas gingivalis (periodontitis-associated) via electrostatic surface binding. This physical removal mechanism — distinct from antibacterial chemistry — supports oral microbiome balance without disrupting beneficial flora. Research published in the Journal of Functional Biomaterials (2025) documents this mechanism specifically for eggshell-derived nHAP.
Nano-particle size (20–80 nm) enables access to exposed dentinal tubules — the pathways that transmit thermal and tactile stimuli to pulp nerves in sensitivity conditions. By occluding these tubules with biomimetic mineral, nano-HAP reduces sensitivity without chemical intervention. Clinical studies show statistically significant reduction in cold-air and tactile sensitivity at two and four weeks of use.
The adsorption properties of hydroxyapatite extend to chromogenic compounds — pigment molecules from food and beverages that bind to enamel surface irregularities. HAP adsorbs these pigments and, through its enamel-smoothing effect, creates a surface that reflects light more uniformly. Systematic review of 17 studies (2023) concluded regular use of HAP-containing oral care products effectively whitens teeth.
Hydroxyapatite has achieved formal regulatory approval as an anti-cavity active in Japan (since 1993) and recognition in the EU via SCCS safety assessment. For brands targeting fluoride-sensitive consumer segments — including natural oral care, children's products, and markets with fluoride restriction concerns — nano-HAP provides a documented efficacy alternative with a biocompatibility profile fluoride cannot match.
Nano-HAP is compatible with standard toothpaste, gel, mouthwash, and dental serum formulation platforms. Effective concentrations range from 1–10% depending on particle grade and intended application. Unlike bioactive glass alternatives, it does not require alkaline pH conditions and is stable across standard oral care formulation pH ranges. Suspension stability is maintained with standard rheology modifiers.
The same surface adsorption property that makes hydroxyapatite effective in oral care creates a novel, chemical-free mechanism for personal care — directly relevant to the aluminium-free deodorant reformulation challenge.
| Technical mechanism and applications | Material safety and composition |
|---|---|
| Physical microbial adsorption Physically captures odour-causing bacteria and fungi to suppress odour without aggressive chemicals. |
Bio-compatible mineral base Composed of the same primary mineral substance that forms human bone. |
| Multi-functional formulation potential Effective in deodorants, long-lasting fragrances, acne skincare, and specialised foot care products. |
Proven safety profile Well-established, non-allergenic material already utilised in food and medical nutrition applications. |
| Broad spectrum targeting Adsorbs bacteria responsible for age-related body odour and common conditions like athlete's foot. |
Safe for sensitive populations Non-irritating functional material suitable for products targeting children and pregnant women. |
Body odour is primarily caused by the metabolic activity of specific bacteria — predominantly Staphylococcus epidermidis, Corynebacterium species, and Malassezia fungi — which convert odourless precursors in sweat into volatile malodorous compounds.
Conventional aluminium-based antiperspirants work by blocking eccrine gland function. Conventional deodorants use fragrance masking, antimicrobial agents (triclosan, alcohol), or pH adjustment. All three approaches involve chemical intervention with the microbiome.
Hydroxyapatite offers a fourth mechanism: physical adsorption of the bacteria themselves onto the mineral surface, reducing the bacterial population available to generate odour compounds. This is the same mechanism that underpins its oral biofilm effect — extended to the body care context.
Hydroxyapatite-LC addresses three independently validated market opportunities, each with distinct buyer profiles and formulation requirements.
Nano-HAP as a fluoride alternative or complement in toothpaste, mouthwash, and dental gel. Three documented mechanisms: remineralisation, bacterial adsorption, and dentine desensitisation.
Physical bacterial adsorption as the active mechanism in aluminium-free deodorants, foot care, and acne-targeting skincare. Addresses the reformulation pressure in K-beauty and EU personal care markets.
GHS non-hazardous, biocompatible mineral base for products targeting sensitive populations. Supports safety-first positioning for baby care, maternity, and hypoallergenic formulations.
Purpose-engineered for cosmetic and oral care applications. Manufactured under Japanese Quasi-Drug Raw Material standards with complete lot traceability.
The difference between industrial hydroxyapatite and functional-grade nano-HAP is not source material — it is process control. Hydroxyapatite-LC is produced via a patented, highly controlled manufacturing process that delivers consistent particle morphology, minimal lot-to-lot variation, and a safety profile documented to Japanese Quasi-Drug standards.
For formulation teams building claims-substantiated products, this documentation is not incidental — it is the foundation of the regulatory dossier.
Made in Japan · Patent ProtectedTechnical data sheets, safety documentation, regulatory reference files, and evaluation samples (50–100g) are available to qualified R&D laboratories and formulation OEMs. Brand owners without their own laboratory are also welcome; we connect you with a formulator. No purchase commitment required for evaluation.
Evaluation samples and full documentation packages sent within 3 business days. Commercial enquiries handled by Technicity Pte. Ltd. (Singapore).